Solid Biosciences Inc. SLDB Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solid Biosciences Inc.'s operating lease liabilities (current)?
- Solid Biosciences Inc. (SLDB) reported operating lease liabilities (current) of $2.19M in Q1 2026.
- How has Solid Biosciences Inc.'s operating lease liabilities (current) changed year-over-year?
- Solid Biosciences Inc.'s operating lease liabilities (current) increased by 17.1% year-over-year, from $1.87M to $2.19M.
- What is the long-term trend for Solid Biosciences Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s operating lease liabilities (current) has grown at a 1.0% compound annual growth rate (CAGR), from $2M to $2.1M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.